AMZN
Amazon.com, Inc.
AMZN has the edge over REYN overall, supported by stronger modeled upside and stronger valuation.
REYN
Reynolds Consumer Products Inc.
REYN trails on the overall score without a compensating advantage in the available component scores.
AMZN Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Weak | |
| Healthy |
AMZN's revenue, profitability and balance sheet are currently healthy, but its cash flow is weak.
REYN Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Healthy | |
| Stable |
REYN's profitability and cash flow are currently healthy, and its revenue and balance sheet are stable.
AMZN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 22x | $267 | — |
| Forward | 27x | $267 | — |
| Cheap | 34x | $415 | +55% |
| Fair | 60x | $745 | +179% |
| Expensive | 102x | $1,262 | +372% |
Historical ranges are pointers, not guarantees.
AMZN has the edge over REYN in the historical PE scenario, which offers more potential upside but is not a forecast.
REYN PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 15x | $23.30 | -4.9% |
| Forward | 15x | $24.50 | — |
| Current | 16x | $24.50 | — |
| Fair | 18x | $27.78 | +13% |
| Expensive | 22x | $34.23 | +40% |
Historical ranges are pointers, not guarantees.
REYN's PE is in its cheap range at 16x. On analysts' estimates for next year's earnings, today's price would be 15x.
AMZN Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Strong growth | |
| Growth | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect earnings and revenue growth for AMZN, with profitability improving.
REYN Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Stable | |
| Stable | |
| Weakening | |
| Limited | |
| High |
Analysts expect REYN's profitability to weaken, with its earnings and revenue holding steady.
AMZN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $9.87 | -20% |
| Q3 2026 | $12.37 | +75% |
| Q2 2026 | $12.43 | +89% |
| Q1 2026 | $8.36 | +36% |
| Q4 2025 | $7.17 | +30% |
| Q3 2025 | $7.08 | +52% |
| Q2 2025 | $6.56 | +57% |
| Q1 2025 | $6.14 | +72% |
| Q4 2024 | $5.53 | +91% |
AMZN has the edge over REYN on earnings, with more consistent year-over-year improvement.
REYN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.64 | +7.2% |
| Q3 2026 | $1.53 | +5.5% |
| Q2 2026 | $1.63 | +10% |
| Q1 2026 | $1.56 | -1.9% |
| Q4 2025 | $1.43 | -14% |
| Q3 2025 | $1.45 | -17% |
| Q2 2025 | $1.48 | -13% |
| Q1 2025 | $1.59 | +1.3% |
| Q4 2024 | $1.67 | +18% |
REYN earned $1.53 per share over the past year, up 5.5% from the year before.
AMZN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $201.9B | +12% |
| Q2 2026 | $200.6B | +20% |
| Q1 2026 | $181.5B | +17% |
| Q4 2025 | $213.4B | +14% |
| Q3 2025 | $180.2B | +13% |
| Q2 2025 | $167.7B | +13% |
| Q1 2025 | $155.7B | +8.6% |
| Q4 2024 | $187.8B | +10% |
AMZN has the edge over REYN on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 14% | +4.2 points |
| Q2 2026 | 14% | +2.3 points |
| Q1 2026 | 13% | +1.3 points |
| Q4 2025 | 12% | +0.4 points |
| Q3 2025 | 9.7% | -1.3 points |
| Q2 2025 | 11% | +1.5 points |
| Q1 2025 | 12% | +1.1 points |
| Q4 2024 | 11% | +3.5 points |
AMZN has the edge over REYN on profitability, with a higher operating margin.
REYN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $944M | +1.4% |
| Q2 2026 | $944M | +0.6% |
| Q1 2026 | $877M | +7.2% |
| Q4 2025 | $1B | +1.4% |
| Q3 2025 | $931M | +2.3% |
| Q2 2025 | $938M | +0.9% |
| Q1 2025 | $818M | -1.8% |
| Q4 2024 | $1B | +1.4% |
REYN's revenue grew through 2021 and has held roughly level since: $944M last quarter, up 1.4% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.1% | -2.9 points |
| Q2 2026 | 12% | +2.1 points |
| Q1 2026 | 8.8% | +3.6 points |
| Q4 2025 | 15% | -0.7 points |
| Q3 2025 | 11% | -1.5 points |
| Q2 2025 | 10% | -2.1 points |
| Q1 2025 | 5.1% | -2.7 points |
| Q4 2024 | 15% | -2.2 points |
REYN's operating margin was 8.1% last quarter, down 2.9 points from the same quarter a year ago.
AMZN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$34.8B | -8202% |
| Q2 2026 | -$8.8B | -2757% |
| Q1 2026 | -$18.2B | -$10.2B |
| Q4 2025 | $14.9B | -16% |
| Q3 2025 | $430M | -87% |
| Q2 2025 | $332M | -96% |
| Q1 2025 | -$8B | -297% |
| Q4 2024 | $17.8B | -36% |
AMZN's free cash flow was −$46.9B over the past year, against $10.6B the year before.
REYN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $9M | -81% |
| Q2 2026 | $45M | -12% |
| Q1 2026 | $27M | +59% |
| Q4 2025 | $200M | +42% |
| Q3 2025 | $48M | -48% |
| Q2 2025 | $51M | -22% |
| Q1 2025 | $17M | -76% |
| Q4 2024 | $141M | -27% |
REYN has the edge over AMZN on cash generation, producing positive trailing cash flow while its opponent burns cash.
AMZN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +26M shares |
| 1 year | +0.8% | +84M shares |
| 3 years | +3.5% | +371M shares |
| 5 years | +6.1% | +629M shares |
| Available history | +8.2% | +829M shares |
AMZN has 10.9B diluted shares, up 0.8% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
| Q1 2023 | — |
| Q4 2022 | — |
| Q3 2022 | — |
| Q2 2022 | $3.3B |
REYN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -100K shares |
| 1 year | +0.7% | +1.4M shares |
| 3 years | +0.9% | +1.8M shares |
| 5 years | +1% | +2M shares |
| Available history | +4.5% | +9.2M shares |
REYN has the edge over AMZN on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q4 2019 | — |
AMZN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.7x | Very low |
| Q2 2026 | 0.3x | Very low |
| Q1 2026 | 0.1x | Very low |
| Q4 2025 | -0.1x | Net Cash |
| Q3 2025 | -0.1x | Net Cash |
| Q2 2025 | -0.0x | Net Cash |
| Q1 2025 | -0.1x | Net Cash |
| Q4 2024 | -0.2x | Net Cash |
AMZN has the edge over REYN on leverage, with a lower net debt burden relative to earnings.
REYN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 2.7x | Moderate |
| Q2 2026 | 2.5x | Moderate |
| Q1 2026 | 2.6x | Moderate |
| Q4 2025 | 2.7x | Moderate |
| Q3 2025 | 3.0x | Moderate |
| Q2 2025 | 2.9x | Moderate |
| Q1 2025 | 2.8x | Moderate |
| Q4 2024 | 2.7x | Moderate |
REYN's net debt is about 2.7 years of its operating earnings (EBITDA), down from 3.0 years a year ago.
AMZN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 57.1 | Neutral |
| Stochastic | 50.0 | Neutral |
AMZN's weekly RSI is 57 (neutral) and its Stochastic is 50 (neutral).
REYN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 55.7 | Neutral |
| Stochastic | 50.9 | Neutral |
REYN's weekly RSI is 56 (neutral) and its Stochastic is 51 (neutral).
AMZN PE vs Consumer Cyclical Sector
| Metric | AMZN | Sector median | Relative |
|---|---|---|---|
| PE | 22x | 18x | 20% above |
| PE % | 4 | 47 | 43 pts below |
AMZN is trading at 22x earnings, a 20% premium to the Consumer Cyclical sector's median of 18x, though its recent earnings include one-off gains.
REYN PE vs Consumer Cyclical Sector
| Metric | REYN | Sector median | Relative |
|---|---|---|---|
| PE | 16x | 18x | 11% below |
| PE % | 31 | 48 | 17 pts below |
REYN has the edge over AMZN on valuation relative to its sector.
AMZN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $253.6 | 5.5% above |
| 20 week MA | $254.9 | 4.9% above |
| 50 week MA | $242.5 | 10% above |
| 100 week MA | $229.6 | 17% above |
| 200 week MA | $191.4 | 40% above |
AMZN has the edge over REYN on trend strength, trading above more of its moving averages.
REYN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $23.0 | 6.5% above |
| 20 week MA | $24.1 | 1.6% above |
| 50 week MA | $23.4 | 4.9% above |
| 100 week MA | $23.6 | 3.9% above |
| 200 week MA | $25.8 | 5% below |
REYN has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 5% below its 200-week average.
AMZN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $93.5 | $158.6 | +70% |
| 2021 | $158.6 | $171.1 | +7.8% |
| 2022 | $171.1 | $85.3 | -50% |
| 2023 | $85.3 | $151.9 | +78% |
| 2024 | $151.9 | $223.8 | +47% |
| 2025 | $223.8 | $232.5 | +3.9% |
| 2026 YTD | $232.5 | $267.4 | +15% |
AMZN has the edge over REYN on returns for 2026, with the stronger performance.
REYN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.6 | $30.5 | +6.8% |
| 2021 | $30.5 | $30.3 | -0.6% |
| 2022 | $30.3 | $30.4 | +0.2% |
| 2023 | $30.4 | $26.8 | -12% |
| 2024 | $26.8 | $27.3 | +1.7% |
| 2025 | $27.3 | $23.3 | -15% |
| 2026 YTD | $23.3 | $24.5 | +5.2% |
REYN has finished lower in three of the last six years. It's up 5.2% so far in 2026.